BioSpecifics Technologies Corp (BSTC): Price and Financial Metrics
BSTC Price/Volume Stats
| Current price | $88.53 | 52-week high | $89.15 |
| Prev. close | $88.40 | 52-week low | $42.00 |
| Day low | $88.44 | Volume | 88,900 |
| Day high | $88.57 | Avg. volume | 61,105 |
| 50-day MA | $76.24 | Dividend yield | N/A |
| 200-day MA | $63.40 | Market Cap | 650.25M |
BSTC Stock Price Chart Interactive Chart >
BioSpecifics Technologies Corp (BSTC) Company Bio
BioSpecifics Technologies Corporation is a biopharmaceutical company that has developed injectable collagenase for twelve clinical indications to date. The company was founded in 1957 and is based in Lynbrook, New York.
Latest BSTC News From Around the Web
Below are the latest news stories about Biospecifics Technologies Corp that investors may wish to consider to help them evaluate BSTC as an investment opportunity.
BioSpecifics Technologies Corp. (BSTC) Investor Presentation - SlideshowThe following slide deck was published by BioSpecifics Technologies Corp. in conjunction with this event.... |
BioSpecifics to Present at the Virtual Oppenheimer & Co. Fall Healthcare Life Sciences and MedTech SummitWILMINGTON, Del., Sept. 14, 2020 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first-in-class collagenase-based product marketed as XIAFLEX® in North America, today… |
The Daily Biotech Pulse: Regulatory Setback For Fennec Pharma, Ligand To Buy Pfenex, Inovio Says Phase 2/3 Coronavirus Vaccine Study Starts In SeptemberScaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Allovir Inc (NASDAQ: ALVR ) BioLife Solutions Inc (NASDAQ: BLFS ) BioSpecifics Technologies Corp. (NASDAQ: BSTC ) (reacted to second-quarter results) CymaBay Therapeutics Inc (NASDAQ: CBAY ) Eton Pharmaceuticals Inc (NASDAQ: ETON ) Fennec Pharmaceuticals Inc (NASDAQ: FENC ) Fulgent Genetics Inc (NASDAQ: FLGT ) Harvard Bioscience, Inc. (NASDAQ: HBIO ) Inari Medical Inc (NASDAQ: NARI ) Kura Oncology Inc (NASDAQ: KURA ) Omeros Corporation (NASDAQ: OMER ) ( announced positive results for the study of its lead asset in COVID-19) Pacira Biosciences Inc (NASDAQ: PCRX ) RedHill Biopharma Ltd (NASDAQ: RDHL ) Rocket Pharmaceuticals Inc (NASDAQ: RCKT ) Seres Therapeutics Inc (NASDAQ: MCRB ) ( reacted to positive late-stage clinical r... |
BioSpecifics Reports Second Quarter 2020 Financial and Operating ResultsWILMINGTON, Del., Aug. 10, 2020 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first-in-class collagenase-based product marketed as XIAFLEX® in North America, today… |
BioSpecifics Technologies: Microcap At Inflection Point Has Upside PotentialInvestment Thesis BioSpecifics Technologies Corp. 5-year share price performance. Source: TradingView BioSpecifics (BSTC) is a small microcap with a market cap of just $474m and revenues of $38.1m in 2019, but the company is entering an exciting phase in its development with the recent FDA approval of its injectable collagenase... |
BSTC Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | 40.10% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | 0.00% |
| 2019 | -6.04% |
Continue Researching BSTC
Want to do more research on Biospecifics Technologies Corp's stock and its price? Try the links below:Biospecifics Technologies Corp (BSTC) Stock Price | Nasdaq
Biospecifics Technologies Corp (BSTC) Stock Quote, History and News - Yahoo Finance
Biospecifics Technologies Corp (BSTC) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...